Evidence map›Paper›PMID 33850943›Full record

ArticleIranian journal of biotechnology2020

Exposing Mouse Oocytes to MitoQ During

Maryam Hosseinzadeh Shirzeyli, Fardin Amidi, Mehdi Shamsara, Hamid Nazarian, Fatemeh Eini, Farhad Hosseinzadeh Shirzeyli, Masoumeh Majidi Zolbin, Marefat Ghaffari Novin, Morteza Daliri Joupari

Abstract read
In one paragraph

Article in Iranian journal of biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maryam Hosseinzadeh ShirzeyliDepartment of Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fardin AmidiDepartment of Anatomical Sciences, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mehdi ShamsaraDepartment of Animal and Marine Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Hamid NazarianDepartment of Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fatemeh EiniFertility and Infertility Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Farhad Hosseinzadeh ShirzeyliDepartment of Animal Science, Faculty of Agriculture and Natural Resources, Science and Research branch, Islamic Azad University, Tehran, Iran.
Masoumeh Majidi ZolbinDepartment of Anatomical Sciences, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Marefat Ghaffari NovinCellular and Molecular Biology Research Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Morteza Daliri JoupariDepartment of Animal and Marine Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMitochondrion is the main indicator of oocyte quality and one of the components of oocyte, which is sensitive to oxidative damage during the maturation process. Mitoquinone mesylate (MitoQ) is a strong antioxidant targeting mitochondria as well as anti-apoptotic agent. However, the effect of MitoQ on the quality of oocytes during

objectivesThis study investigated the possible effects of MitoQ on maturation and developmental competency in mice oocytes. MATERIALS AND

methodsThe oocytes were collected at germinal vesicle stage from 6-8-week old female NMRI mice and then cultured in TCM-199 medium supplemented with 0, 0.01, 0.02 and 0.04 µM MitoQ. The sham group was treated with DMSO (0.01% v.v). Then intracellular Glutathione (GSH), reactive oxygen species (ROS) levels, mitochondria membrane potential (ΔΨm), as well as

resultsThe results showed that between three dose of MitoQ, the 0.02 µM significantly increased nuclear maturation rate, GSH level, fertilization rate and blastulation (92.6, 231.7, 90.19 and 81.66%, respectively) than the

conclusionThe results indicated that supplementation of IVM medium with MitoQ (specially 0.02 µM) enhance maturation and fertilization rate. In conclusion, MitoQ might be considered as a novel component that could be added to IVM media.

Indexed as

AntioxidantAssisted reproductionFertilizationMitoQOocyte in vitro maturation

Identifiers

PMID33850943
PMCPMC8035425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.